Sources: Google DeepMind spinout Isomorphic Labs is in talks to raise ~$5B at a ~$50B valuation; the AI drug discovery startup last raised $2.1B in May (Bloomberg)
Isomorphic Labs is negotiating a massive new funding round to fuel its artificial intelligence pharmaceutical research. Spun out of Google DeepMind, the computational venture seeks approximately $5 billion from investors to dramatically scale its operations. This proposed deal would assign the startup an estimated valuation of roughly $50 billion. The negotiations follow closely behind a prior $2.1 billion funding round that the enterprise closed in May.
Key points
The startup originated directly as an artificial intelligence drug discovery spinout from…: The startup originated directly as an artificial intelligence drug discovery spinout from Google DeepMind.
A successful round would represent a substantial escalation in the company's overall capi…: A successful round would represent a substantial escalation in the company's overall capital scale.
The negotiations signal massive ongoing investor interest in specialized artificial intel…: The negotiations signal massive ongoing investor interest in specialized artificial intelligence applications for drug development.
Sources checked by our analysis pipeline: 1
Bloomberg: |
Washington Post: |
Calder Mchugh / Politico: |
Politico: |
Molly White / Citation Needed: |
Sasha Rogelberg / Fortune: |
Katherine Schwartz / Bloomberg: |
Bloomberg: |
Ryan Christoffel / 9to5Mac: |
Bloomberg: |
Mark Gurman / Bloomberg: |
Madison Mills / Axios: |
Madison Mills / Axios: |
Connie Loizos / TechCrunch: |
Mike Butcher / Pathfounders: |
Rafe Rosner-Uddin / Financial Times: |
Bloomberg: |
Yueqi Yang / The Information: |
Financial Times: |
Bloomberg: |
Bloomberg: |
Isaac Kasahara / Pangram: |
Sawdah Bhaimiya / CNBC: |
Spencer Soper / Bloomberg: |
Bloomberg: |
Jagmeet Singh / TechCrunch: |
Reuters: |
Deborah Mary Sophia / Reuters: |
SemiAnalysis: |
Ivan Mehta / TechCrunch: |
Murad Hemmadi / Globe and Mail: |
This is a Techmeme archive page. It shows how the site appeared at 7:15 PM ET, November 4, 2026.
The most current version of the site as always is available at our home page. To view an earlier snapshot click here and then modify the date indicated.
Software defense at scale is seeing direct integration with emerging artificial intelligence architectures designed specifically for code remediation. By targeting critical operating system flaws, this automated workflow proves that specialized models can actively resolve complex system weaknesses before malicious actors exploit them. The approach underscores a shifting landscape where vulnerability management relies on machine-driven identification and remediation.
Company President Greg Brockman announced the operational milestone during a Wall Street Journal technology conference held in Napa, California. The artificial intelligence firm is accelerating its fundraising efforts to capitalize on recent business momentum after previously delaying its debut. This strategic shift reflects an intensified market race against rival Anthropic as both entities pursue public market readiness.
Corporate clients have become the primary revenue driver for the artificial intelligence company as it plans its long-term financial path. Leadership has targeted a multi-year transition toward becoming a publicly traded entity. The shift toward business adoption reflects the platform's commercial monetization model.